Skip to main content

Table 3 Comparison of PRVEPs in affected eyes between baseline, FU1and FU2 assessments in ONTT+ Group

From: The effect of optic neuritis treatment trial (ONTT) combined corticosteroid regimen on pattern reversal visual evoked potentials: a prospective follow-up study

PRVEP measure

Median (IQR)

Overall p value (Friedman’s rank test)

P value (Wilcoxon’s Signed Ranks test)

Baseline (n = 29)

FU1 (n = 29)

FU2 (n = 20)

Baseline vs. FU1 (n = 29)

FU1 vs FU2 (n = 20)

Baseline vs. FU2 (n = 20)

N75L

97.25 (79.8–106.4)

78.4 (69.6–85.8)

74.1 (60.9–86.6)

0.021

0.008

0.472

0.003

P100L

124.4 (121–142.7)

110.9 (98.2–123.2)

106.7 (94.6–119.8)

0.001

< 0.001

0.171

< 0.001

N145L

160.1 (148.5–178.6)

151.0 (138.1–162.9)

151.2 (132.7–158.2)

0.016

0.012

0.732

0.008

N75A

0.7 (0.3–1)

1.0 (0.25–1)

0.5 (0.2–1.0)

0.476

0.303

0.740

0.434

P100A

4.7 (2.8–6.7)

4.6 (2.1–7)

3.75 (2.3–5.5)

0.534

0.746

0.177

0.456

N145A

3.5 (2.5–6.5)

3.4 (1.7–4.4)

4.25 (2.9–5.9)

0.157

0.50

0.204

0.948

  1. L Latency, A Amplitude, IQR Inter Quartile Range